Status: Not yet recruiting
Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas
The purpose of this study is to determine whether combining of Temozolomide and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with Malignant Gliomas. The effectiveness and safety of CIK cells for the treatment of Malignant Glioma is also evaluated.
Participants needed: 80
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: The First People's Hospital of ChangzhouUpdated: Jul 10, 2015
Eligibility criteria
Not listed